Klinger Shannon Thyme sold MRNA
September 1, 2026 · Form 4 insider transaction
Klinger Shannon Thyme sold 3,471 shares of Moderna, Inc. at $139.95 per share, a transaction worth $485.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,471
Price
$139.95
Total value
$485.8K
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after74,129
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.